DNM1L and lung adenocarcinoma: Therefore, although further studies are required to validate the prognostic significance of DRP1 in early‐stage lung adenocarcinoma, our results suggest that biomarkers related to mitochondrial reprogramming might help to stratify patients based on the risk of postoperative recurrence and thus warrant further exploration.